Ignite Creation Date:
2025-12-25 @ 2:44 AM
Ignite Modification Date:
2026-02-20 @ 1:46 PM
Study NCT ID:
NCT02300233
Status:
COMPLETED
Last Update Posted:
2022-04-13
First Post:
2014-11-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
The COMPASS Study: A Study of Volanesorsen (Formally ISIS-APOCIIIRx) in Patients With Hypertriglyceridemia
Sponsor:
Ionis Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-02-05
Start Date Type:
ACTUAL
Primary Completion Date:
2016-07-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-01-24
Completion Date Type:
ACTUAL
First Submit Date:
2014-11-20
First Submit QC Date:
None
Study First Post Date:
2014-11-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2022-01-13
Results First Submit QC Date:
None
Results First Post Date:
2022-04-13
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2018-05-09
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2022-03-17
Last Update Post Date:
2022-04-13
Last Update Post Date Type:
ACTUAL